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  SENSITIVE AND SELECTIVE SPECTRO-
PHOTOMETRIC DETERMINATION OF 
PANTOPRAZOLE SODIUM IN PHARMA-
CEUTICALS USING PERMANGANATE 
A simple visible spectrophotometric method is described for the determination of 
pantoprazole sodium sesquihydrate (PSS). The method is based on the for-
mation of a brown colored product on treating PSS with permanganate in neutral 
medium, the absorbance being measured at 350 nm. The experimental con-
ditions for the assay were optimized. The absorbance is found to increase 
linearly with the concentration of PSS and the calibration graph is linear in the 
range of 2.5-40.0 μg ml
-1 with a linear regression coefficient of 0.998. The 
calculated molar absorptivity value is 1.27×10
4 l mol
-1 cm
-1 and the corres-
ponding Sandel sensitivity is 0.0341 µg cm
-2. The limits of detection (LOD) and 
quantification (LOQ) are calculated to be 0.49 and 1.47 µg ml
-1, respectively. 
Intra-day and inter-day accuracy expressed as relative error were better than 
2.0% and the corresponding precision (RSD) was less than 2.5 %. The deve-
loped and validated method was applied to the determination of the active 
ingredient in a tablet dosage form and the results obtained agreed well with 
those of the reference method. The accuracy and reliability of the method were 
ascertained by performing recovery experiments via standard-addition pro-
cedure. 
Key words: pantoprazole sodium sesquihydrate; assay; spectrophoto-
metry; permanganate; pharmaceuticals. 
 
 
Pantoprazole sodium sesquihydrate (PSS) is che-
mically known as sodium 5-(difluoromethoxy)-2–{[(3,4-
dimethoxy-2-pyridinyl) methyl]sulfinyl}-1H-benzimida-
zole sesquihydrate (Fig. 1). It is used as an antiulce-
rative agent [1] by inhibiting the gastric acid secretion. 
Pantoprazole sodium sesquihydrate is immensely used 
for the cure of erosion and ulceration of esophagus 
caused by a gastroesophageal reflux disease. It is 
pharmaceutically formulated as gastro-resistant tab-
lets containing 40 or 20 mg pantoprazole sodium ses-
quihydrate. 
PSS is a non-official drug substance and there 
are only a few reports on the determination of this 
drug in pharmaceutical substances including a dosa-
ge form. A few methods based on HPLC [2-5], densi-
tometric HPTLC [6], derivative UV-spectrophotometry 
[7] and difference UV-spectrophotometry [8] have been 
reported for the assay of PSS in commercial dosage 
forms. Several manipulation steps are involved in some 
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of these methods which are not simple for the routine 
analysis of dosage forms. 
 
Figure 1. The structure of pantoprazole sodium sesquihydrate. 
Visible spectrophotometry is still considered to 
be a very convenient and low-cost technique, and 
hence widely used for the determination of pharma-
ceuticals in bulk and dosage forms [9-13]. The re-
ported spectrophotometric methods for PSS [14-18] 
suffer from one or the other disadvantages such as a 
narrow linear range of applicability [16], lack of selec-
tivity [17,18], lower sensitivity and for use of organic 
solvents as the reaction medium/expensive reagents O. ZENITA DEVI et al.: SENSITIVE AND SELECTIVE SPECTROPHOTOMETRIC…  CI&CEQ 16 (1) 97−102 (2010) 
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[14,15] (Table 1). Hence, there is a need to develop a 
simple, selective and sensitive procedure for the de-
termination of PSS in pharmaceuticals. 
The present communication describes the deve-
lopment and validation of a visible spectrophotometric 
method for the determination of PSS in pure form and 
in dosage forms. The method involves treating the 
drug with potassium permanganate in neutral medium 
and subsequent measurement of the absorbance at 
350 nm. Permanganate has earlier been used for the 
assay of thioxanthines [19], isoniazid [20], methyl thio-
uracil [21], chloramphenicol [22], amidopyrine [23], 
valdecoxib [24], nicotine [25], tramodol HCl [26], ce-
furoxime [27], diloxamide [28] and pentacozine [29], 
to mention a few, and its use for the determination of 
PSS in neutral medium has not been reported. The 
method developed offers the advantages of simplicity, 
speed, accuracy and precision without the need for 
costly equipment/chemicals. 
EXPERIMENTAL DATAILS 
Apparatus 
All absorbance measurements were performed 
using a Systronics model 106 digital spectrophoto-
meter (Ahmedabad, India) provided with 1-cm match-
ed quartz cells. 
Reagents and standards 
All chemicals and reagents used were of ana-
lytical-reagent grade and distilled water was used 
throughout the investigation. 
Standard PSS solution.  Pharmaceutical grade 
PSS which was certified to be 98.98 % pure was re-
ceived as a gift from Cipla India Ltd., Mumbai, India, 
and used as received. Standard PSS solution (100 µg 
ml
-1) was prepared by dissolving a calculated quantity 
of a pure drug in water. 
Two brands of tablets containing PSS, pan-
todac-20 (Aristo Pharmaceuticals Ltd., Mumbai, India) 
and pantop-40 (Cipla Ltd., Mumbai, India) used in the 
investigation were purchased from local commercial 
sources. 
Potassium permanganate (300 µg ml
-1). An ap-
proximately 0.02 M solution was prepared by dissol-
ving about 0.80 g of KMnO4 (Merck, Mumbai, India) in 
water, diluting to 250 ml in a calibrated flask and stan-
dardized using H.A Bright’s procedure [30]. The stock 
standard solution was then diluted appropriately with 
water to get a 300 µg ml
-1 working concentration. 
Procedures 
Preparation of calibration graph 
Different aliquots of 0.0, 0.25, 0.5, 1.0, 2.0, 3.0 
and 4.0 ml of standard PSS solution (100 µg ml
-1) 
were transferred into a series of 10 ml standard volu-
metric flasks and the total volume in each flask was 
adjusted to 5 ml with water. To each flask, 1 ml of 300 
µg ml
-1 KMnO4 was added. The contents of each flask 
were mixed well and kept aside for 10 min with occa-
sional shaking. The volume was made up to the mark 
with water and the absorbance was measured at 350 
nm vs. reagent blank prepared in a similar manner. 
The calibration graph was prepared by plotting 
the increasing absorbance values vs. concentrations 
of PSS. The concentration of the unknown was read 
from the calibration graph or deduced from the re-
gression equation derived using the Beer’s law data. 
Table 1. The comparison of the Performance characteristic of the existing spectrophotometric methods with the proposed method 
Sl. No.  Reagent(s) used  Methodology 
Linear range, µg ml
-1 
(ε / l mol
-1 cm
-1) 
Remarks Ref. 
1. Trivalent  iron  1:2 Chelated in EtOH medium 
measured at 455 nm. 
30-300  Ethanolic medium used, less 
sensitive. 
14,15 
2.  a) DDBQ  C-T complex measured at 457 nm.  10-60  Narrow linear range, use of 
organic solvent. 
16 
 b)  Iodine  C-T complex measured at 293 
and 359 nm. 
18-142  Measured at shorter wave-
length, use of organic solvent. 
16 
  c) Cu (II)-eosin  Ternary complex measured at 549 nm. 4-26  Narrow linear range, involves 
liquid-liquid extraction and use 
of organic solvent medium. 
16 
3. BrO3
–-Br
–/MO, IC  Unbleached colour of MO/IC measured 
at 510/610 nm. 
0.12-1.5 (1.8×10
5) 
0.5-6.0 (4.1×10
4) 
Less selective, accurate 
concentration of bromate and 
dyes to be known. 
17 
4.  BrO3
--Br
 -/Fe(II)- 
-SCN
- or 
Fe(II)-tiron
 
Fe(II)-SCN
- complex
 or Fe(II)-tiron 
complex measured at 470 or 670 nm.
0.12-1.25 (2.2×10
5) 
0.25-2.5 (1.2×10
5) 
Less selective.  18 
5.  KMnO4 in neutral 
medium 
Brown color measured at 350 nm.  2.5-40.0 (1.27×10
4)  Wide linear dynamic range and 
high sensitivity. 
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Procedure for tablets 
Twenty tablets were weighed accurately and 
ground into a fine powder. A quantity of the powder 
containing 10 mg of PSS was accurately weighed into 
a 100 ml calibrated flask and 60 ml of water added. 
The content was shaken for about 20 min; the volume 
was diluted to the mark with water and mixed and fil-
tered using a Whatman No. 42 filter paper. The filtrate 
containing PSS at a concentration of 100 μg ml
-1 in 
PSS was subjected to analysis by the procedure des-
cribed above. 
Placebo blank analysis 
A placebo blank of the composition: talc (20 
mg), starch (10 mg), acacia (15 mg), methyl cellulose 
(10 mg), sodium citrate (10 mg), magnesium stearate 
(15 mg) and sodium alginate (10 mg) was made and 
its solution was prepared as described under “assay 
of tablets” and then subjected to analysis. 
Procedure for the determination of PSS in a 
synthetic mixture 
To the placebo blank of the composition descri-
bed above, 10 mg of PSS was added and homoge-
nized, transferred to a 100 ml standard flask and the 
solution prepared as described under “assay of tab-
lets”. The solution was mixed well and filtered using a 
Whatman No. 42 filter paper. The resulting solution 
containing PSS at the concentration of 100 μg ml
-1 
was assayed (n = 5) by the same procedure descri-
bed above. The analysis was done to study the inter-
ferences of excipients such as talc, starch, acacia, 
methyl cellulose, sodium citrate, magnesium stearate 
and sodium alginate. 
RESULTS AND DISCUSSION 
In neutral medium, potassium permanganate 
quantitatively oxidizes PSS resulting in the formation 
of MnO2 [31], which is brown in color with an absorp-
tion maximum at 350 nm. In a neutral solution, per-
manganate is only reduced to give MnO2, wherein Mn 
is in a +4 oxidation state. The initial study showed that 
the absorbance of the brown color was linearly de-
pendent on the concentration of PSS. Based on the 
above observations, a simple spectrophotometric me-
thod to the determination of PSS was developed and 
validated as per the current ICH guidelines [32]. 
The various experimental parameters affecting 
the formation of the reaction product were optimized. 
The effect of the KMnO4 concentration 
To study the effect of the KMnO4 concentration, 
varying volumes of 300 μg ml
-1 KMnO4 (0.25-1.5 ml) 
were made to react with 4 ml of 100 μg ml
-1 PSS into 
a series of 10 ml volumetric flasks. It is apparent from 
Fig. 2 that the absorbance increased with increasing 
the volume of the KMnO4 solution and it became con-
stant at 0.75 ml. Thus, the adoption of 1.0 ml of 300 
µg ml
-1 KMnO4 in the final solution proved to be ade-
quate for the maximum concentration of PSS used in 
the calibration curve. 
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Figure 2. The effect of KMnO4 on absorbance 
of the reaction product (MnO2). 
The effect of time 
To study the effect of time, a fixed concentration 
of PSS (40 μg ml
-1) was made to react with 1 ml of 
300  μg ml
-1 KMnO4 solution; absorbance readings 
were recorded at different time of 5, 10, 15, 20 and 30 
min. The oxidation reaction was completed in 10 min, 
and the color was stable up to 30 min in the presence 
of the reaction product(s) (Fig. 3). 
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Figure 3. The effect of time on absorbance 
of the reaction product (MnO2). 
Method validation procedures 
The proposed method has been validated for li-
nearity, sensitivity, precision, accuracy, selectivity and 
recovery. 
Linearity and sensitivity 
Under optimum conditions, a linear relation was 
obtained between absorbance and concentration of 
PSS in the range 2.5-40.0 µg ml
-1  (Fig. 4). The 
calibration graph is described by the equation: O. ZENITA DEVI et al.: SENSITIVE AND SELECTIVE SPECTROPHOTOMETRIC…  CI&CEQ 16 (1) 97−102 (2010) 
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Y = a + bX 
where Y = absorbance, a = intercept, b = slope and X = 
= concentration, obtained by the method of least 
squares. The correlation coefficient, intercept and slo-
pe for the calibration data are summarized in Table 2. 
Sensitivity parameters such as apparent molar ab-
sorptivity and Sandell sensitivity values, the limits of 
detection and quantification calculated as per the cur-
rent ICH guidelines are compiled in Table 2. The li-
mits of detection (LOD) and quantification (LOQ) were 
calculated according to the same guidelines using the 
formulas: 
LOD = 3.3σ/s and LOQ = 10σ/s 
where σ is the standard deviation of five reagent blank 
determinations and s is the slope of the calibration 
curve. 
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Figure 4. Calibration curve. 
Table 2. Sensitivity and regression parameters 
Parameter Method 
λmax / nm  350 
Linear range, µg ml
-1 2.5-40.0
 
Molar absorptivity(ε), l mol
-1 cm
-1 1.27×10
4 
Sandell sensitivity
a, µg cm
-2 0.0341 
Limit of detection (LOD), μg ml
-1 0.49 
Limit of quantification (LOQ), μg ml
-1 1.47 
Intercept (a) 0.0172 
Slope (b) 0.0119 
Standard deviation of a (Sa) 0.0376 
Standard deviation of b (Sb) 0.0010 
Regression coefficient (r) 0.9983 
a
Limit of determination as the weight in µg per ml of solution, which 
corresponds to an absorbance of A = 0.001 measured in a cuvette of 
cross-sectional area 1 cm
2 and l = 1 cm 
Precision and accuracy 
Intra-day precision and accuracy of the pro-
posed method were evaluated by replicate analysis 
(n = 5) of calibration standards at three different con-
centration levels in the same day. Inter-day precision 
and accuracy were determined by assaying the cali-
bration standards at the same concentration levels on 
five consecutive days. Precision and accuracy were 
based on five consecutive days. Precision and accu-
racy were based on the calculated relative standard 
deviation (RSD, %) and relative error (RE, %) of the 
found concentration compared to the theoretical one, 
respectively (Table 3). 
Selectivity 
The proposed method was tested for selectivity 
by placebo blank and synthetic mixture analyses. A 
convenient aliquot of the placebo blank solution pre-
pared as described earlier was subjected to analysis 
according to the recommended procedure. There was 
no interference by the inactive ingredients. 
A separate experiment was performed with the 
synthetic mixture. The analysis of the synthetic mix-
ture solution prepared above yielded recoveries rang-
ing between 107.27 and 110.51%, with a standard 
deviation of 1.36-1.47%. The results of this study are 
presented in Table 4 indicating that the inactive 
ingredients did not interfere in the assay. These 
results further demonstrate the accuracy, as well as the 
precision of the proposed methods. 
Table 4. Recovery of the drug from the synthetic mixture 
PSS in synthetic mixture taken, μg ml
-1  PSS recovered
a±SD, %
20.0 110.51±1.47 
30.0 108.04±1.36 
40.0 107.27±1.42 
a
Mean value of five determinations 
Application to formulations 
In order to evaluate the analytical applicability of 
the proposed method to the quantification of PSS in 
commercial tablets, the results obtained by the pro-
posed method were compared to those of the refe-
rence method [5] by applying student’s t-test for accu-
racy and F-test for precision. The reference method 
involves the HPLC determination of pantoprazole so-
Table 3. Evaluation of intra-day and inter-day accuracy and precision (RE: relative error; RSD: relative standard deviation) 
PSS taken, μg ml
-1  Intra-day accuracy and precision  Inter-day accuracy and precision 
PSS found, μg ml
-1  RE, %  RSD, %  PSS found, μg ml
-1  RE, %  RSD, % 
10.0 9.90  1.00  1.15  9.79  2.10  1.28 
20.0 19.53  2.34  1.26  19.65  1.75  1.37 
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dium in pharmaceuticals with UV-detection at 289 nm. 
The results (Table 5) show that the student’s t- and F- 
-values at 95 % confidence level are less than the 
theoretical values, which confirmed that there is a good 
agreement between the results obtained by the pro-
posed method and the reference method with respect 
to accuracy and precision. 
Recovery studies 
The accuracy and validity of the proposed me-
thod were further ascertained by performing recovery 
studies. Pre-analyzed tablet powder was spiked with 
pure PSS at three concentration levels (50, 100 and 
150% of that in tablet powder) and the total was found 
by the proposed method. The added PSS recovery 
percentage values ranged between 104.27 and 111.8% 
with the standard deviation of 1.04-1.48% (Table 6) 
indicating that the recovery was good and that the co 
formulated substance did not interfere with the deter-
mination. 
CONCLUSIONS 
A new method which is selective and sensitive 
has been developed and appropriately validated for 
the assay of pantoprazole sodium sesquihydrate in 
pharmaceuticals. The proposed method was found to 
be superior to some of the reported spectrophoto-
metric methods with respect to simplicity, sensitivity, 
selectivity, a linear dynamic range of applicability and 
cost-effectiveness. In addition, the method is bestowed 
with twin advantages of simplicity of operations and 
the possibility of carrying them out with the common 
laboratory instrument. Since the proposed method re-
quires the use of only one reagent (KMnO4), it cer-
tainly is the most cost-effective of all the existing spe-
ctrophotometric methods. 
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NAUČNI RAD 
  OSETLJIVO I SELEKTIVNO SPEKTROFOTOMETRIJSKO 
ODREĐIVANJE NATRIJUM PANTOPRAZOLA U FARMA-
CEUTSKIM PROIZVODIMA KORIŠĆENJEM 
PERMANGANATA 
Određivanje pantoprazolnatrijum-seskvihidrata (PSS) je izvršeno korišćenjem jedno-
stavne vidljive spektrofotometrijske metode. Metoda je bazirana na formiranju braon 
obojenih proizvoda prilikom tretiranja PSSS sa permanganatom u neutralnoj sredini. Ap-
sorbanca je merena na 350 nm. Eksperimentalni uslovi analize su optimizovani. Apsor-
banca se linearno povećava sa povećanjem koncentracije PSS, a kalibracioni dijagram 
je linearan u opsegu 2,5 do 40,0 μg ml
-1, sa koefeicijentom linearne regresije od 0,998. 
Vrednost molarne apsorpcije je 1,27×10
4 l mol
-1 cm
-1 i odgovara Sandel-ovoj osetljivosti 
od 0,0341 µg cm
-2. Limiti detekcije (LOD) i kvantifikacije (LOQ) iznose 0,49 i 1,47 µg ml
-1, 
redom. Intra-dnevna i inter-dnevna tačnost izražene kao relativna greška su bolje od 2,0%, 
a odgovarajuća preciznost (RSD) je manja od 2,5%. Razvijena i validovana metoda je 
primenjena za određivanje aktivne komponente u dozama tableta i dobijeni rezultati su u 
skladu sa onim dobijenim referentnom metodom. Tačnost i pouzdanost metode su potvr-
đene izvođenjem eksperimenata standardnom metodom. 
Ključne reči: pantoprazolnatrijum seskvihidrat; analiza; spektrofotometrija; per-
manganat; farmaceutski proizvodi. 
 
 